dopamine hydrochloride has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akça, M; Belet, N; Çakıcı, Ö; Çiftdoğan, DY; Dinç, F; Erbaş, İC; Erdeniz, EH; Keleş, YE; Kuyucu, N; Öncel, S; Tapısız, A; Ulu, NK; Yeşil, E; Yılmaz, AT | 1 |
| Chae, B; Ha, SW; Hong, SI; Kim, B; Kim, JS; Kim, SM; Kim, WY; Kim, YJ; Kwon, H; Ryoo, SM | 1 |
2 other study(ies) available for dopamine hydrochloride and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Evaluation of possible COVID-19 reinfection in children: A multicenter clinical study.
Topics: Adolescent; Adult; Child; COVID-19; Humans; Reinfection; Retrospective Studies | 2023 |
Respiratory rate‑oxygenation (ROX) index for predicting high-flow nasal cannula failure in patients with and without COVID-19.
Topics: Cannula; COVID-19; Humans; Noninvasive Ventilation; Oxygen Inhalation Therapy; Respiratory Insufficiency; Respiratory Rate; Retrospective Studies | 2024 |